Pharma article - December 3, 2018
Anders Lönner has suddenly passed away
“It is with great regret and sadness we announce this very tragic and unexpected information,” says the Board of Directors, Karo Pharma. “Anders Lönner has suddenly and unexpected passed away. Our thoughts go to his family and those closest to him.” Anders Lönner joined Karo Pharma as Executive Chairman of the Board in 2014. He has […]
Pharma article - November 23, 2018
Exclusive R&D interview: David Fredrickson
In an interview in Nordic Life Science, the Head of AstraZeneca’s Oncology Business unit, shared his insights on current drug development within oncology and how we can create faster access to innovative medicines. “Drug development within oncology has evolved to become more flexible,” said David Fredrickson, head of AstraZeneca’s oncology business unit. “Clinical trials with […]
Pharma article - November 30, 2016
New era for cancer diagnostics
Liquid biopsies, sequencing and upgraded software tools are among some of the recent and ongoing trends in cancer diagnostics. Developments in the diagnostic sector have vastly improved the ability to identify cancer diseases at the early stages of tumor formation. However, several cancer types cannot be identified early enough, while others may be recognized in […]
Pharma article - November 17, 2016
Nanotechnology in drug delivery
The rapid development within nanotechnology drug delivery is creating new possibilities to treat common diseases and improving pharmaceuticals. Safety aspects and competitionwith established treatments are however some of the obstacles on the way to a real breakthrough. Nanotechnology is rapidly growing in the field of medicine and more specifically in drug delivery with potential therapeutic […]
Pharma article - July 27, 2016
Q&A: Drug delivery
Hans Lennernäs, professor in biopharmaceutics at Uppsala University, has extensive experience in developing drug delivery methods. NLS asked him about his research and ongoing activities in the field. He spoke about the latest progress and challenges in drug delivery, nanotechnology and the importance of multidisciplinary collaborations. Your research aims to develop novel strategies for tissue […]
Pharma article - April 15, 2016
Tackling diabetes
Much effort is being made to develop new medicines for diabetes and recent findings indicate the potential for new and improved pharmaceuticals. Diabetes is one of the largest global diseases and there is a huge unmet need for efficient medicines. The firsthand medication for type 2 diabetes has long been the oral drug metformin. Glitazones […]
